TECON BIOLOGY Co.LTD (SHE:002100)
China
· Delayed Price · Currency is CNY 6.27
-0.06 (-0.95%)
May 23, 2025, 2:45 PM CST
TECON BIOLOGY Co.LTD Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 699.13 | 605.05 | -1,363 | 280.78 | -702.79 | 1,720 | Upgrade
|
| Depreciation & Amortization | 884.19 | 884.19 | 802.92 | 713.19 | 704.95 | 448.11 | Upgrade
|
| Other Amortization | 17.39 | 17.39 | 11.11 | 12.49 | 39.34 | 41.15 | Upgrade
|
| Loss (Gain) From Sale of Assets | -4.5 | -4.5 | -3.9 | -0.23 | 36.72 | 60.29 | Upgrade
|
| Asset Writedown & Restructuring Costs | 41.58 | 41.58 | 43.7 | 37.82 | 458.49 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 1.87 | 1.87 | -3.46 | -17.81 | -30.92 | -28.79 | Upgrade
|
| Other Operating Activities | 543.75 | 179.93 | 583.11 | 264.25 | 213.53 | 271.9 | Upgrade
|
| Change in Accounts Receivable | -605.88 | -605.88 | 855.47 | -528.52 | 759.92 | -1,085 | Upgrade
|
| Change in Inventory | 367.9 | 367.9 | 861.26 | -548.38 | 158.82 | -2,923 | Upgrade
|
| Change in Accounts Payable | 9.48 | 9.48 | -65.21 | 78.85 | -98.63 | 896.03 | Upgrade
|
| Change in Other Net Operating Assets | -307.66 | -307.66 | 53.2 | 50.36 | - | - | Upgrade
|
| Operating Cash Flow | 1,620 | 1,162 | 1,752 | 327.99 | 1,533 | -600.86 | Upgrade
|
| Operating Cash Flow Growth | -16.58% | -33.68% | 434.11% | -78.60% | - | - | Upgrade
|
| Capital Expenditures | -497.33 | -626.46 | -1,001 | -1,430 | -1,752 | -929.74 | Upgrade
|
| Sale of Property, Plant & Equipment | 6.35 | 6.35 | 0.89 | 27.89 | 3.35 | - | Upgrade
|
| Cash Acquisitions | - | - | -359.19 | -31.55 | -37.98 | -0.47 | Upgrade
|
| Divestitures | - | - | - | - | 14.1 | - | Upgrade
|
| Investment in Securities | -130 | -130 | 580.53 | -656.24 | -6.63 | 59.8 | Upgrade
|
| Other Investing Activities | -13.7 | 0.09 | 4.11 | 17.58 | 4.3 | - | Upgrade
|
| Investing Cash Flow | -634.68 | -750.02 | -775 | -2,072 | -1,775 | -806.41 | Upgrade
|
| Long-Term Debt Issued | - | 6,820 | 4,915 | 4,982 | 5,871 | 5,340 | Upgrade
|
| Total Debt Issued | 6,749 | 6,820 | 4,915 | 4,982 | 5,871 | 5,340 | Upgrade
|
| Long-Term Debt Repaid | - | -6,786 | -5,882 | -4,740 | -5,611 | -3,466 | Upgrade
|
| Total Debt Repaid | -7,046 | -6,786 | -5,882 | -4,740 | -5,611 | -3,466 | Upgrade
|
| Net Debt Issued (Repaid) | -297.29 | 33.7 | -966.46 | 242.3 | 260.23 | 1,874 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 2,045 | 30.47 | Upgrade
|
| Common Dividends Paid | -166.56 | -173.32 | -520.34 | -260.85 | -701.74 | -404.41 | Upgrade
|
| Other Financing Activities | 8.75 | 8.75 | -18.39 | 1,652 | - | - | Upgrade
|
| Financing Cash Flow | -455.1 | -130.87 | -1,505 | 1,634 | 1,604 | 1,500 | Upgrade
|
| Net Cash Flow | 529.98 | 280.98 | -528.37 | -110.82 | 1,361 | 92.8 | Upgrade
|
| Free Cash Flow | 1,122 | 535.4 | 750.48 | -1,102 | -219.37 | -1,531 | Upgrade
|
| Free Cash Flow Growth | 34.89% | -28.66% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 6.39% | 3.12% | 3.94% | -6.49% | -1.40% | -12.77% | Upgrade
|
| Free Cash Flow Per Share | 0.82 | 0.39 | 0.56 | -0.82 | -0.20 | -1.42 | Upgrade
|
| Cash Income Tax Paid | 190.23 | 191.38 | 110.88 | 214.53 | 121.89 | 119.8 | Upgrade
|
| Levered Free Cash Flow | 749.6 | 189.22 | 1,155 | -1,785 | -89.81 | -2,227 | Upgrade
|
| Unlevered Free Cash Flow | 857.21 | 301.06 | 1,308 | -1,630 | 39 | -2,104 | Upgrade
|
| Change in Net Working Capital | 90.98 | 485.38 | -2,299 | 1,162 | -1,331 | 2,915 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.